Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study to Assess the Effect of Trimetazidine on Index of Microcirculatory Resistance (IMR), Measured by Coronary Pressure and Temperature Wire, in Patients With Stable Coronary Artery Disease

NCT02107144 is registered in ClinicalTrials.gov with Clinical Hospital Center Zemun as lead sponsor.

NCT NCT02107144
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02107144 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study to Assess the Effect of Trimetazidine on Index of Microcirculatory Resistance (IMR), Measured by Coronary Pressure and Temperature Wire, in Patients With Stable Coronary Artery Disease
Lead sponsor
Clinical Hospital Center Zemun
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2014
Completion date
March 31, 2023
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, microcirculation, vascular resistance